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Abstract We have analyzed the expression and localization of
bovine transient receptor potential-C1 (bTRPC1) in bovine
aortic endothelial cells, and its possible involvement in the
store-independent calcium influx induced by basic fibroblast
growth factor (bFGF). RT-PCR experiments confirmed the
existence of two btrpc1 mRNA isoforms; conversely, the btrpc3
gene was not transcribed. Anti-TRPC1 antibody revealed the
presence of the protein in the membrane-rich compartment only.
Application of anti-TRPC1 during the response to bFGF caused
a partial but significant reduction of calcium entry. This is the
first evidence of TRP channel involvement in a non-capacitative
calcium influx induced by a biologically relevant agonist such as
the angiogenic factor bFGF in native endothelial cells. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The recently identi¢ed transient receptor potential (TRP)
family of channel proteins has been suggested to be involved
in calcium in£ux triggered by extracellular agonists in several
excitable and non-excitable cell types [1^4].
This family of proteins is widely associated to store-depen-
dent, or capacitative, calcium entry, a widespread process
whose mechanism(s) of activation and physiological role are
still not completely understood. However, it is now accepted
that TRP proteins represent a highly heterogeneous group,
including both store-dependent and store-independent (or
non-capacitative) channels [1,4]. The archetypal TRP from
Drosophila melanogaster is activated by PLC [1] ; the other
Drosophila channel, TRPL, is insensitive to store depletion,
and opened by fatty acids, such as arachidonic and linolenic
acid [5]. The mammalian homologs TRPC3, TRPC6 and
TRPC7 are directly opened by diacylglycerol, even if the in-
terpretation of the experimental data is not unequivocal [6,7].
Other groups have proposed more complex patterns of acti-
vation, suggesting that other intracellular messengers and co-
factors may be involved [8]. Notably, recent evidence supports
the hypothesis of an enzymatic activity of some members of
the family, that would be involved in the regulation of the
properties of the pore [9]. The heterogeneity of this family
extends to the biophysical properties : while some members
(such as Drosophila TRP) are reported to be quite selective
for calcium, others (including TRPC1, TRPC3, TRPC4) are
non-selective cationic channels, permeable to Ca2, Na and
K, carrying an outwardly rectifying current [10^12].
Most of the data have been obtained on proteins hetero-
logously expressed in transfected cells [13^18]. This has two
major drawbacks: on one hand, it limits the information
about the physiological role of endogenously expressed TRP
channels in the di¡erent cell types; on the other, transfected
TRP subtypes may form heteromultimers with other members
of the family or interact with accessory proteins expressed by
the host cell, thus complicating the interpretation of the ex-
perimental results.
Recently, endogenous trpc genes (and in some cases the
related protein) have been described in some cell types, such
as smooth muscle cells [19], salivary glands cells, in which they
may be involved in the control of secretion [20,21], B lympho-
cytes, with a suggested role in cell viability [22], and vascular
endothelial cells [23^25].
In endothelial cells, calcium entry is a critical physiological
event: it is triggered by vasoactive agents and by growth fac-
tors, binding respectively to G-protein coupled and tyrosine
kinase receptors [26,27].
A well studied agonist for these cells is basic ¢broblast
growth factor (bFGF) or FGF-2, a peptidic growth factor
belonging to the family of FGFs, that exerts a potent moto-
genic and proliferative e¡ect on endothelial cells [28]. Binding
to speci¢c tyrosine kinase receptors, this factor is able to in-
duce di¡erent transduction pathways, among them the recruit-
ment and activation of cytosolic phospholipase A2 and release
of arachidonic acid and its metabolites, the so called eicosa-
noids. These processes are the basis of the angiogenic role of
the factor in proliferative diseases such as cancer [29].
In a previous work we showed the ability of bFGF to in-
duce a non-capacitative calcium in£ux in a line of bovine
aortic endothelial cells (BAE-1 cells) in culture [27]. This in-
£ux is dependent on the tyrosine kinase activity of bFGF
receptors and it is due to the opening of calcium-permeable
cationic channels. Similar events are triggered by arachidonic
acid in the same cells, and this pathway is involved in the
control of cell proliferation [30].
Since on the same cell type Chang et al. [23] reported the
expression of bovine trpc1 (btrpc1) and btrpc3 genes, we
sought to assess the role of the related proteins in the non-
capacitative calcium in£ux induced by bFGF.
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2. Materials and methods
2.1. Cell culture
BAE-1 (European Cell Culture Collection, UK) were maintained in
Dulbecco’s modi¢ed Eagle’s medium (DMEM, BioWhittaker, Ver-
viers, Belgium) supplemented with 10% heat-inactivated fetal calf se-
rum (FCS, BioWhittaker), 50 Wg/ml gentamycin and 2 mM glutamine,
at 37‡C, in a humidi¢ed atmosphere of 5% CO2 in air.
For electrophysiological and cyto£uorimetric measurements, mono-
layers were growth arrested by shifting exponentially growing cells to
DMEM containing 1% FCS 24^72 h before measurements. Only non-
con£uent, single isolated cells were used, at passages 2^8. External
solutions containing the agents were applied by a microperfusion sys-
tem (delay 3^5 s).
Unless otherwise speci¢ed, products were from Sigma (St. Louis,
MO, USA); bFGF was from Amersham Pharmacia Biotech (UK).
2.2. RT-PCR
Total RNA was prepared from BAE-1 cells, both starved (24 h in
1% FCS DMEM) and exponentially growing (10% FCS DMEM) with
the SV Total RNA Isolation System from Promega (Madison, WI,
USA). 1 Wg of total RNA was reverse-transcribed into ¢rst-strand
cDNA by using random hexameric primers (0.5 Wg) and AMV Re-
verse Transcriptase (Reverse Transcription System, Promega). Ali-
quots of the cDNA products were used as templates for PCR ampli-
¢cation. Expression of btrpc1 gene was studied according to data and
procedures published for BAE cells by Chang et al. [23], who cloned
the btrpc1 gene (GenBank accession number AF012900). Two primers
were used, speci¢c for btrpc1, that bracket the splice region in the N-
terminal domain and reveal the presence of two mRNA isoforms,
btrpc1 a (longer) and btrpc1 b (shorter): 5P-GAACATAAATTGCG-
TAGATG-3P (left) and 5P-CGATGAGCAGCTAAAATGACAG-3P
(right).
Cycling conditions were: 2 min at 94‡C followed by 30 cycles of
1 min at 94‡C, 1 min at 55‡C, 1 min at 72‡C, and a ¢nal extension of
7 min at 72‡C. Control reactions were performed in the absence of
cDNA. PCR products were separated on 2% agarose gels by electro-
phoresis and visualized by staining with ethidium bromide.
To study the expression of the btrpc3 gene in BAE-1 cells, we tried
three di¡erent sets of speci¢c primers reported in the literature.
The ¢rst was the set described by Chang et al. [23], that cloned a
partial cDNA sequence of btrpc3 (accession number AF012902):
5P-TGACTTCCGTTGTGCTCAAATATG-3P (left) and 5P-CCTT-
CTGAAGCCTTCTCCTTCTGC-3P (right). The second set of primers
was reported by Kamouchi et al. [11], that cloned another fragment of
btrpc3 cDNA sequence (accession number AJ006781): 5P-CAA-
TCTGGTACGAGAACC-3P (left) and 5P-CAGTCCAAGTGA-
ACTGTG-3P (right). The third set was designed on the human
trpc3 sequence (accession number U47050) by Balzer et al. [31], work-
ing on porcine aortic endothelial cells : 5P-ATGCTGTTTTAC-
CACTGTAG-3P (left) and 5P-TGAGTTAGACTGAGTGAAGAG-
3P (right).
Control mRNA for the metabolic enzyme glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) was ampli¢ed with the following
primers: 5P-GGCATCGTGGAGGGACTTATGA-3P (left) and
5P-ATGCCAGTGAGCTTCCCGTTGAGC-3P (right) [32].
Oligonucleotides were synthesized by Sigma Genosys.
2.3. Immunoblotting
Subcon£uent monolayers of BAE-1 cells, plated in 10 cm Petri
dishes, were washed with cold PBS, added with 1 mM phenylmethyl-
sulfonyl £uoride (PMSF), and then lysed in a bu¡er containing 20
mM Tris, pH 7.4, 0.1 M NaCl, 5 mM MgCl2, 1% Triton X-100, 0.5%
sodium deoxycholate, 2 Wg/ml aprotinin, 1 mM PMSF, and homog-
enized on ice by passing through a syringe needle. Lysates were cen-
trifuged for 5 min at 12 000Ug and supernatants boiled 5 min in a
sample denaturing bu¡er. 100 Wg of total proteins per lane was sep-
arated by electrophoresis on a 8% SDS^polyacrylamide gel, trans-
ferred to a polyvinylidene £uoride (PVDF) membrane and blocked
overnight in Tris-bu¡ered saline (pH 7.5) plus 5% bovine serum al-
bumin and 1% Tween 20.
The PVDF membrane was incubated with the K-TRPC1 primary
antibody (Alomone Labs, Israel, diluted 1:300), for 1 h at 25‡C,
washed three times with Tris-bu¡ered saline, and then incubated
with horseradish peroxidase-conjugated secondary antibody (Dako,
Denmark, 1:3000), followed by a second set of three washes with
Tris-bu¡ered saline. Bands were visualized by chemiluminescence
with ECL Western Blotting Detection System (Amersham).
As a control, K-TRPC1 was preincubated overnight at room tem-
perature with the corresponding antigen peptide (Alomone, 5:1 pep-
tide:antibody), and subsequently used for immunoblotting.
Membrane and cytosolic fractions were obtained lysing subcon£u-
ent BAE-1 cells in 25 mM Tris (pH 7.4), 0.3 M sucrose, 1 mM PMSF
and 2 Wg/ml aprotinin on ice and homogenized as above. Debris was
removed by centrifugation at 8000Ug for 15 min at 4‡C. The resulting
supernatant was centrifuged at 100 000Ug for 1 h at 4‡C to obtain a
pellet (membrane fraction), that was resuspend in the same bu¡er, and
a supernatant (cytosolic fraction). 100 Wg of both fractions were sep-
arated by electrophoresis and processed as described above.
2.4. Immunocytochemistry
BAE-1 cells were plated on plastic at a density of 5000 cells/cm2 in
10% FCS DMEM; after 24 h, cells were washed twice with PBS, ¢xed
for 45 min in 4% paraformaldehyde at room temperature, washed
twice in PBS, then blocked with normal goat serum (10% in PBS)
and incubated overnight with primary antibody (K-TRPC1, 1:200
¢nal concentration). Antigen was visualized by incubation with ap-
propriate biotinylated secondary antiserum, the Vector kit (ABC kit,
Vector Laboratories, Burlingame, CA, USA), 3,3P-diaminobenzidine
(0.015%) and hydrogen peroxide (0.008%) as chromogen. As a con-
trol, K-TRPC1 was preincubated with the corresponding antigen pep-
tide as described above for immunoblotting. Stained cells were ob-
served on a Olympus IX50 inverted microscope (Olympus Optical Co,
Hamburg, Germany).
2.5. Calcium measurements
Cells on glass coverslips were loaded with the acetoxymethyl ester
form of indo-1 (Molecular Probes, Eugene, OR, USA; 45 min incu-
bation with 2.5 WM indo-1 AM at 37‡C). The medium was then
replaced with standard Tyrode solution, of the following composition,
in mM: NaCl 154; KCl 4; CaCl2 2; MgCl2 1; Na^HEPES 5; glucose
5.5; NaOH to pH 7.4. The coverslips were placed on an inverted IM-
35 Zeiss microscope with a £uorescence objective (Nikon 100U). Di-
aphragms were used to observe single cells. Fluorescence signals were
taken at excitation wavelength of 380 nm and emissions of 400 and
480 nm using a spectrophotometer from Cairn Ltd., Newnham, UK.
Due to the uncertainties of the cytosolic free calcium concentration
([Ca2]i) calibration in our experiments, [Ca2]i is expressed as a ratio,
R, of emitted £uorescence (400/480), corrected for background and
auto£uorescence online. The increment, vR, was calculated as a di¡er-
ence between the basal level and the peak of the response. All experi-
ments were performed at 22^24‡C.
Student’s t-test was used to determine statistically signi¢cant di¡er-
ences among the groups. The level of signi¢cance was P6 0.05. All
values are given as mean þ S.D.
2.6. Electrophysiology
Cells used in the experiments were £at and ¢rmly attached to the
dish (35 mm dishes; Corning, Denmark) and bathed in standard
Tyrode solution. Patch-clamp pipette contained, in mM: KCl 15,
K-aspartate 118, MgCl2 3, EGTA 5, HEPES 5, NaGTP 0.4, Na2ATP
5, Na2phosphocreatine 5, KOH to pH 7.3.
Whole-cell patch-clamp recordings were performed using electrodes
of 3^8 M6 resistance connected to an EPC-7 ampli¢er (List, Ger-
many). Data were stored on a DAT recorder system (Sony, Japan)
and sampled at 200 ms intervals (5 Hz). Voltage clamp protocols and
o¡-line analysis were performed with pCLAMP software (Axon In-
struments, Burlingame, CA, USA). All experiments were performed at
22^24‡C.
3. Results
3.1. Expression of transcripts for btrpc1 by BAE-1 cells
RT-PCR experiments in BAE-1 cells using the primers spe-
ci¢c for btrpc1 revealed the presence of two fragments of 282
and 180 bp, con¢rming the existence of two mRNA isoforms
produced by alternative splicing, btrpc1 a and btrpc1 b (Fig.
1A). The lengths are in agreement with those described by
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Chang et al. in the same cell type, that they have shown to
endogenously express btrpc1 [23]. Comparable levels of ex-
pression could be observed both in growth-arrested and in
exponentially growing cells (Fig. 1A).
We next checked for the presence of btrpc3 transcripts, as
reported in the same cell type [23]. In our conditions, the
expression of btrpc3 mRNA was not detectable neither in
starved cells (1% FCS DMEM for 24 h) nor in exponentially
growing cells (10% FCS) (Fig. 1B). Di¡erent working condi-
tions were tried, by changing MgCl2 concentration, cycling
parameters and sets of primers. Starting with the same
cDNA, the control mRNA of the metabolic enzyme GAPDH
was ampli¢ed, excluding problems within the sample (Fig.
1B).
3.2. Expression of bTRPC1 protein and its plasma-membrane
localization
Expression of bTRPC1 protein was assessed by the use of a
commercial rabbit polyclonal antiserum (K-TRPC1, Alomone
Labs, Israel) against a peptide corresponding to the sequence
QLYDKGYTSKEQKDC of the human protein (amino acids
557^571), as described [33] ; the amino acid sequence is highly
homologous in bovine (14/15 identical : proline in place of
serine). According to the current models based on the hydro-
phobicity of the amino acid sequence of TRPC1, this antigen
should be localized near the outer mouth of the pore, between
the ¢fth and the sixth transmembrane segments [19,34]
Western blot experiments were performed in order to iden-
tify the expression and localization of the protein. A band of
Fig. 1. btrpc expression in BAE-1 cells. A: mRNA detected by RT-
PCR in exponentially growing (10% FCS) and serum-starved (1%
FCS) BAE-1 cells. Both isoforms of btrpc1 were present, distin-
guishable upon their size di¡erences (282 and 180 bp). Predicted
size of GAPDH PCR product was 188 bp. B: btrpc3 mRNA was
detected neither in exponentially growing (10% FCS) nor in serum-
starved (1% FCS) BAE-1 cells. The positive control GAPDH
mRNA could be ampli¢ed in the same samples.
Fig. 2. bTRPC1 protein expression in BAE-1 cells. A: SDS^PAGE
and immunoblotting with K-TRPC1 were performed on total lysate
from serum-starved (lane 1) and exponentially growing (lane 2)
BAE-1 cells. Lanes 3 and 4 represent respectively membrane prepa-
ration and cytosolic fraction of exponentially growing cells. The ar-
row indicates reactivity to K-TRPC1. B: Western blot analysis per-
formed with the same protein samples as in (A). Immunoreactivity
to K-TRPC1 was competed o¡ by preincubation of the antibody
with the antigen peptide, underlying the speci¢city of the primary
antibody.
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about 100 kDa molecular weight was detectable in the total
lysate from both serum-starved and exponentially growing
cells (Fig. 2A, lanes 1 and 2). The band was not detectable
by Western blot staining with secondary antibody only (data
not shown).
When the membrane and soluble fractions were separated,
the protein was still present in the membrane-rich compart-
ment, while not detectable in the soluble fraction (Fig. 2A,
lanes 3 and 4 respectively).
To assess the speci¢city of the staining, preincubation with
the control antigen peptide (Alomone, 5:1 peptide:antibody)
was performed: the labelling was competed o¡ by peptide, as
expected for a competitive e¡ect (Fig. 2B); the additional
bands present both in Fig. 2A,B were also present in blots
performed, as control, with secondary antibody only, under-
lying an aspeci¢c staining by this secondary antibody (data
not shown).
As a further test of the plasma-membrane localization of
bTRPC1, we performed immunocytochemical experiments by
incubating non-permeabilized cells with the K-TRPC1 anti-
body. A plasma-membrane-associated staining pattern was
clearly evident in BAE-1 cells (Fig. 3A,C), that could be abol-
ished by staining cells with K-TRPC1 preincubated with the
antigen peptide (Fig. 3B,D).
3.3. bFGF-induced calcium entry is partially inhibited by
K-TRPC1
In a previous work we have described the ability of bFGF
to trigger a calcium entry from the extracellular medium in
BAE-1 cells through the opening of store-independent calcium
channels [27].
In order to check the potential involvement of bTRPC1
channels in the calcium in£ux observed in response to
bFGF, we performed single-cell cytosolic calcium measure-
ments using the indo-1 probe.
Application of 1:100 K-TRPC1 to the external bath in rest-
ing conditions failed to exert any detectable e¡ect on basal
Ca2 levels (n = 6; Fig. 4A). Interestingly, the addition of the
antibody during the response to 100 ng/ml bFGF (corre-
sponding to the saturating dose [27]) caused a partial reduc-
tion of the response in 17 out of 26 of the cells tested: K-
TRPC1, in the continuous presence of bFGF, signi¢cantly
(P6 0.05) inhibited the factor-induced calcium increase. The
mean increment of R(400/480), vR, at the peak of the re-
Fig. 3. Immunolocalization of bTRPC1 protein in BAE-1 cells. A,C: Immunoreactivity for bTRPC1 protein in non-permeabilized cells; B,D:
staining with K-TRPC1 was competed o¡ by preincubation of the antibody with the antigen peptide; A,B show a BAE-1 cell at higher magni¢-
cation.
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sponse to bFGF was 0.22 þ 0.12; at the end of antibody ad-
dition, in the continuous presence of the agonist, it was
0.14 þ 0.10 (n = 17). In individual cells in which the reduction
occurred, the percentage of reduction ranged from 15 to 71%
(mean: 41 þ 29%). In many cases the antibody was washed
out in the continuous presence of bFGF and the e¡ect could
be reverted (Fig. 4B).
To exclude any aspeci¢c e¡ects of K-TRPC1 that may in-
volve also other mechanisms of calcium permeation, we em-
ployed a polyclonal rabbit antiserum (produced against rat
immunoglobulins; kind gift of Dr. C. Dati) ; this serum did
not have any e¡ects on basal calcium levels (n = 14, Fig. 5A)
nor on the bFGF induced calcium in£ux (n = 8, Fig. 5B).
As a further test, whole-cell patch-clamp experiments were
performed, in the voltage clamp mode at a Vhold of 350 mV,
in order to exclude an indirect e¡ect of the antibody on in-
wardly rectifying potassium currents that are highly expressed
in these cells ; indeed a reduction of these currents might lower
the driving force for calcium, thus a¡ecting calcium in£ux. As
tested by comparison of voltage ramps (from 3150 to +50
mV) applied before and after superfusion of the antibody into
the bath, no e¡ect could be detected in resting conditions,
where inward rectifying potassium currents are the main com-
ponent (data not shown).
4. Discussion
In spite of the great amount of data that has accumulated
in the last years on the molecular nature of TRP proteins,
much has still to be understood about the pathways that
underlie their activation; while the store-operated paradigm
has gained wide consensus, it is now apparent that other,
more direct mechanisms linking receptor activation to channel
opening can explain the experimental ¢ndings obtained for
several TRP subtypes in several experimental models
[1,5,10]. Another issue which still needs a more detailed study
is the functional relevance of these channels, and speci¢cally
of the calcium in£ux that can be associated to the activation
of many of them.
These limitations in our knowledge are probably due at
least to two reasons. The ¢rst is the great heterogeneity of
these molecules: their properties and tissue distribution are
highly variable [1,35]. The second is that functional properties
have been studied mostly on channels heterologously ex-
pressed in transfected cells [13^18]. This approach may have
relevant consequences, because it is widely accepted that sev-
eral features of ionic channels are dependent on cell-speci¢c
factors, such as accessory proteins. Moreover, since the actual
subunit composition of mammalian TRPC homologs is un-
known, endogenous proteins in mammalian cells heterolo-
gously expressing trpc genes may contribute to channel struc-
ture, conferring to it di¡erent features, such as thapsigargin
sensitivity [10].
Endogenous trpc mRNA has been detected in vascular en-
dothelial cells [23^25]. In BAE cells, Chang et al. presented
evidence for the endogenous expression of btrpc1, btrpc3,
btrpc4 and btrpc5 mRNA [23].
In the same cell type, we have previously shown that
growth factors, and in particular bFGF, binding to tyrosine
kinase receptors, induce a non-capacitative calcium entry [27].
bFGF is a potent mitogenic factor for endothelial cells (in-
cluding BAE-1 cells) and is strongly involved in angiogenic
processes. In the present work, we provide evidence for the
presence of bTRPC1 proteins in BAE-1 cells, for their mem-
brane localization and for their involvement in the calcium
in£ux activated by bFGF. We have centered our e¡orts on
btrpc1 and btrpc3, the two subtypes better characterized in
this cell type [23]. Moreover, both types have been associated
Fig. 4. Inhibition of bFGF-induced calcium in£ux by K-TRPC1 in
BAE-1 cells. Single-cell [Ca2]i measurements with indo-1 probe. A:
Application of K-TRPC1 (1:100) failed to exert any detectable e¡ect
on basal calcium levels. B: Stimulation with 100 ng/ml bFGF in-
duced an increase in [Ca2]i, that was partially and reversibly inhib-
ited by K-TRPC1 (1:100) addition to the bath during the response.
Fig. 5. Lack of e¡ects of the non-speci¢c rabbit polyclonal antise-
rum (r Ig). Single-cell [Ca2]i measurements with indo-1 probe. A:
Superfusion with the rabbit polyclonal antiserum did not exert any
e¡ect on resting calcium levels. B: bFGF-induced [Ca2]i increase
was not a¡ected by the addition of the rabbit polyclonal antiserum.
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with non-capacitative calcium in£ux, at least in some exper-
imental models [1,10].
Interestingly, we found expression of btrpc1 mRNA (and
protein), but not of btrpc3. bTRPC1 is expressed in exponen-
tially growing cells (medium containing 10% FCS), as well as
in serum-starved ones; thus, apparently, its expression is not
dependent on cell cycle.
Chang et al. [23] described also the presence of btrpc3 tran-
scripts in BAE cells, and showed that its expression varied
following hormonal stimulation. The discrepancies with our
results may be ascribed to the di¡erent culture conditions (the
data by Chang et al. were obtained on con£uent cells and by
exposition to di¡erent patterns of external agonists).
Western blot and immunocytochemical analyses give the
¢rst evidence for the native expression of bTRPC1 protein
in endothelial cells ; moreover, we show that it is localized
at the plasma membrane, while no detectable protein levels
are present in the cytosol. This is the ¢rst description of en-
dogenous expression of bTRPC1 protein in native endothelial
cells, and one of the ¢rst for native tissues [19,33]. In cyto-
£uorimetric calcium measurements, the antibody against
bTRPC1 (K-TRPC1) protein did not exert any detectable ef-
fect on basal cytosolic calcium level ; on the other hand, when
K-TRPC1 was applied in presence of bFGF, a signi¢cant re-
duction of the response to the factor was measured, suggest-
ing an involvement of bTRPC1 channels in the calcium in£ux
induced by the factor. The e¡ect of the antibody could be
reverted by washing it out; while this is not the general case
for the action of antibodies on membrane proteins such as
channels, it is in agreement with the ¢ndings reported by other
authors for di¡erent antibodies (see e.g. [36]).
The observation that K-TRPC1 can block only a fraction of
the response triggered by bFGF, and that in some cells the
response is not apparently a¡ected by the antibody, suggests
that other channels (either belonging to the TRPC family or
not) can be activated by the factor in these cells. Alternatively,
bTRPC1 may form heteromultimers with other members of
the family [37].
Electrophysiological measurements in the whole-cell con¢g-
uration were performed as controls aimed to exclude any as-
peci¢c e¡ects on membrane properties. In particular, an inhi-
bition of an inwardly rectifying potassium current, highly
expressed in these cells, may reduce the driving force for cal-
cium; this could mimic an inhibitory e¡ect on calcium entry.
The lack of e¡ect of the antibody on potassium currents al-
lows us to exclude this possibility.
Thus, bTRPC1 appears to be involved in the generation of
non-capacitative calcium in£ux, in accordance with the obser-
vations by other groups [10].
Taken together, the data presented here provide the ¢rst
evidence for an involvement of a channel belonging to the
TRPC family in a calcium in£ux activated by a biologically
relevant agonist such as bFGF in native endothelial cells.
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